Phio Pharmaceuticals Corp. - Common Stock — Cash Flow (NASDAQ:PHIO) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Documents

Quarterly Annual

Cash from operating activities -8.8 M-11.86 M-12.13 M-10.75 M-7.11 M-7.98 M -12.2 M Cash from investing activities -19 K-51 K-121 K-5 0008 000-12 K -4 000 Cash from financing activities 16.13 M21.72 M-26 K7.41 M4 M23.64 M 14.43 M Free cash flow -8.8 M-11.86 M-12.13 M-10.75 M-7.11 M-7.98 M -12.2 M

News

What's Going On With Tiny Cancer Biotech Phio Pharmaceuticals On Thursday? - Phio Pharma (NASDAQ:PHIO)

Phio Pharmaceuticals stock soars after strong cancer treatment results

Cancer Biotech Phio Pharmaceuticals Stock Surges As Trial Shows Tumor Clearance At Highest Dose In Skin Cancer Patients - Phio Pharma (NASDAQ:PHIO)

Phio Pharmaceuticals reports 70% response rate in skin cancer trial

Phio to begin FDA-required toxicology study for cancer drug PH-762

Phio completes enrollment in Phase 1b trial of skin cancer therapy

Phio’s INTASYL PH-762 wins immunomodulatory solution of the year

3 Penny Stocks to Watch Now, 11/4/25 - TipRanks.com

Phio Pharmaceuticals raises $13.4 million through warrant exercise

Why Is Phio Pharmaceuticals Stock Soaring Today? - Phio Pharma (NASDAQ:PHIO)

Phio’s skin cancer treatment shows promising tumor clearance results

Phio Pharmaceuticals appoints David Deming as lead independent director